AU6620596A - Use of transglutaminase modulators to promote wound healing - Google Patents
Use of transglutaminase modulators to promote wound healingInfo
- Publication number
- AU6620596A AU6620596A AU66205/96A AU6620596A AU6620596A AU 6620596 A AU6620596 A AU 6620596A AU 66205/96 A AU66205/96 A AU 66205/96A AU 6620596 A AU6620596 A AU 6620596A AU 6620596 A AU6620596 A AU 6620596A
- Authority
- AU
- Australia
- Prior art keywords
- transglutaminase
- modulators
- wound healing
- promote wound
- promote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB1996/001785 WO1998004245A1 (en) | 1996-07-25 | 1996-07-25 | Use of transglutaminase modulators to promote wound healing |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6620596A true AU6620596A (en) | 1998-02-20 |
Family
ID=10787759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU66205/96A Abandoned AU6620596A (en) | 1996-07-25 | 1996-07-25 | Use of transglutaminase modulators to promote wound healing |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6620596A (en) |
WO (1) | WO1998004245A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3012923B2 (en) * | 1998-01-26 | 2000-02-28 | 新潟大学長 | Drug for treating CAG repeat disease |
WO1999065516A1 (en) * | 1998-06-17 | 1999-12-23 | Yeda Research And Development Co. Ltd. | Methods and compositions for treating diseases mediated by transglutaminase activity |
US6794414B1 (en) * | 1998-06-17 | 2004-09-21 | Yeda Research And Development Co. Ltd. | Method and compositions for treating diseases mediated by transglutaminase activity |
JP4755113B2 (en) * | 2004-01-30 | 2011-08-24 | クアーク・ファーマスーティカルス、インコーポレイテッド | Oligoribonucleotides and methods of use thereof for the treatment of fibrotic conditions and other diseases |
WO2006100679A2 (en) * | 2005-03-22 | 2006-09-28 | Quark Pharmaceuticals, Inc. | Recombinant antibodies against human type ii transglutaminase and uses thereof |
US8946201B2 (en) | 2007-08-27 | 2015-02-03 | Saint Louis University | Methods for inhibiting TGF-β |
KR20090028880A (en) * | 2007-09-17 | 2009-03-20 | 재단법인서울대학교산학협력재단 | Pharmaceutical compositions for preventing or treating fibrosis |
WO2010033507A1 (en) * | 2008-09-16 | 2010-03-25 | St. Louis University | Method of enhancing tgf-beta signalling |
BRPI1009325A2 (en) * | 2009-03-19 | 2016-03-08 | Univ Queensland | targets for growth factor signaling and therapy method |
US20130236480A1 (en) * | 2010-06-02 | 2013-09-12 | Pierre-Louis Tharaux | Transglutaminase 2 inhibitors for use in the prevention or treatment of rapidly progressive glomerulonephritis |
GB201209096D0 (en) | 2012-05-24 | 2012-07-04 | Medical Res Council Technology | Compounds |
CA3067905A1 (en) * | 2017-06-23 | 2018-12-27 | Vivier Canada Inc. | Putrescine topical formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5021440A (en) * | 1989-07-31 | 1991-06-04 | Merck & Co., Inc. | Imidazole compounds and their use as transglutaminase inhibitors |
US5124358A (en) * | 1990-01-16 | 1992-06-23 | The Board Of Reagents The University Of Texas System | Effect of transglutaminase inhibition on microfilariae development and macrofilariae viability |
US5885982A (en) * | 1992-03-23 | 1999-03-23 | Dolynchuk; Kenneth Nicholis | Use of transglutaminase inhibitor for the treatment of scar tissue |
DE69328228T2 (en) * | 1992-04-21 | 2000-12-21 | Ajinomoto Co., Inc. | Wound medication |
-
1996
- 1996-07-25 WO PCT/GB1996/001785 patent/WO1998004245A1/en active Application Filing
- 1996-07-25 AU AU66205/96A patent/AU6620596A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998004245A1 (en) | 1998-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9902770A3 (en) | Modulators of tissue regeneration | |
AU1957697A (en) | Methods and compositions for the modulation of cell proliferation and wound healing | |
AU2557397A (en) | Removal of tissue | |
AU5520998A (en) | Reduction of hair growth | |
PL315627A1 (en) | Modulators of anchoring protein functions | |
AU3599597A (en) | Reduction of hair growth | |
AU5799098A (en) | Preparation of gabapentin | |
AU7592998A (en) | Modulators of tissue regeneration | |
ZA955010B (en) | Enhanced crosslinking of natural tissues | |
AU9319798A (en) | Reduction of hair growth | |
AU5730298A (en) | Reduction of hair growth | |
AU2909597A (en) | Use of hollow microcapsules | |
AU6620596A (en) | Use of transglutaminase modulators to promote wound healing | |
AU5158298A (en) | Use of phenylcyclopropylamines to stimulate tear secretion | |
AU7290898A (en) | Preparation of fagopyritols and uses therefor | |
AU2557097A (en) | Enhanced expression of transgenes | |
AU4306197A (en) | Use of inhibitors of the activity of retinoic acid to promote healing | |
AU4672199A (en) | Modulation of angiogenesis and wound healing | |
AU5427398A (en) | Cytoperfusion of tissue specimens | |
AU3560595A (en) | Preparation of cisapride | |
AU5487298A (en) | Novel therapeutic application of pyrrole derivatives | |
AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
AU1347799A (en) | Hydrocolloid wound dressing and the method of making and using the same | |
AU2870597A (en) | Treatment of liquid | |
AU1933297A (en) | Manufacture of elongate members |